Hongkai Zhang

8PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Sequence analysisGene and molecular therapyCancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 30, 2026
HFB301001, an OX40-based immunotherapy, drives Treg clearance and CTL activation through optimized OX40 receptor clustering.

Jiliang Zhao, Dongping Zhang, Yun-Yueh Lu

|Mar 16, 2026
Mining antibody functionality via AI-guided structural landscape profiling.

Stanislav S Terekhov, Nikita V Ivanisenko, Nan Zhang

|Dec 10, 2025
Chimeras co-targeting antigens and FcγRIIb trigger degradation of extracellular soluble proteins and pathological aggregates.

Mingjuan Du, Na Li, Tianqi Li

|Nov 18, 2025
Oncolytic virus-induced IL-1β+ monocyte-IL-6+ CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer.

Fan Li, Jingru Chen, Yuanke Li

|Jul 18, 2025
The crystal structure of coronavirus RBD-TMPRSS2 complex provides basis for the discovery of therapeutic antibodies.

Zhuoqian Zhao, Qi Yang, Xiaoce Liu

|Jun 12, 2021
High-throughput functional screening for next-generation cancer immunotherapy using droplet-based microfluidics.

Yuan Wang, Ruina Jin, Bingqing Shen

Pageof 2

Frequent Collaborators

3 joint publications

Alexey V Stepanov

2 joint publications

Yu Guo

2 joint publications

Haitao Yang

2 joint publications

Yinkai Duan